This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Oregon Health & Science University, Southern Research Institute, The University of Texas System. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:




Years Active: 2024
Title: Shuklendu D Karyakarte: Innovator in Antiviral Agents
Introduction
Shuklendu D Karyakarte is a notable inventor based in Birmingham, Alabama. He has made significant contributions to the field of antiviral agents, particularly through his innovative work on 6-aza-nucleoside prodrugs. His research focuses on developing compounds that can effectively inhibit various viral infections.
Latest Patents
Karyakarte holds a patent for "6-aza-nucleoside prodrugs as antiviral agents for treating virus infections." This patent addresses the use of these prodrugs in treating a wide range of viral infections, including human immunodeficiency virus (HIV), human papillomavirus (HPV), and even emerging viruses such as COVID-19. The patent outlines methods for utilizing these compounds to combat infections caused by numerous viruses, showcasing the potential impact of his work in the medical field.
Career Highlights
Throughout his career, Karyakarte has worked with esteemed organizations such as Southern Research Institute and Oregon Health & Science University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Karyakarte's notable coworkers include Omar Moukha-Chafiq and Ashish Kumar Pathak. Their collaborative efforts have further advanced the research and development of antiviral agents.
Conclusion
Shuklendu D Karyakarte's innovative work in the field of antiviral agents highlights his commitment to addressing viral infections through scientific research. His contributions, particularly in the development of 6-aza-nucleoside prodrugs, have the potential to make a significant impact on public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile